ENTITY
SMARTSCORE: 3/5
Dexcom Inc

Dexcom Inc (DXCM US)

48
Analysis
Health CareUnited States
DexCom Inc. is a medical device company focused on the design and development of continuous glucose monitoring systems for people with diabetes. The Company has developed a small implantable device that continuously measures glucose levels in subcutaneous tissue just under the skin, and a small external receiver to which the sensor transmits glucose levels at specified intervals.
more
bullishDexcom Inc
12 Jul 2025 05:00

DexCom Eyes Explosive Growth with Game-Changing Type 2 Strategy—Is This Its Biggest Pivot Yet?

DexCom’s latest earnings and strategy pivot have reignited investor attention as the company recalibrates its focus on the vast, underpenetrated...

Logo
424 Views
Share
bullishDexcom Inc
23 May 2025 11:00

DexCom: Non-Insulin Type 2 Diabetes Market Penetration Be A Breakthrough Move?

DexCom, Inc. reported its first-quarter 2025 earnings, demonstrating a commendable 14% organic revenue growth from the previous year. The U.S....

Logo
308 Views
Share
bullishDexcom Inc
24 Feb 2025 05:00

Dexcom Inc.: Will Sensor Tech Advancements Solidify Its Lead In Continuous Glucose Monitoring?

DexCom Inc.'s latest earnings for the fourth quarter of 2024 reports a period of strategic growth and investment, aligning with the company's...

Logo
261 Views
Share
bullishDexcom Inc
30 Oct 2024 20:00

DexCom Inc.: These Are The 7 Biggest Factors Driving Its Performance In 2025 & Beyond! - Major Drivers

Dexcom, a leader in glucose monitoring technology, recently held its third-quarter 2024 earnings call, presenting both noteworthy achievements and...

Logo
172 Views
Share
bullishDexcom Inc
05 Aug 2024 06:00

DexCom Inc.: A Tale Of Product Innovation and Pipeline Development! - Major Drivers

DexCom, Inc. recently reported its second quarter earnings for 2024, presenting a mix of achievements and challenges that provide a nuanced view...

Logo
213 Views
Share
x